GTF2E2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.057400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.954600E-01
Normal-vs-Stage2
3.244400E-01
Normal-vs-Stage3
4.084800E-01
Normal-vs-Stage4
5.978200E-02
Stage1-vs-Stage2
1.148380E-01
Stage1-vs-Stage3
3.768400E-01
Stage1-vs-Stage4
1.147790E-01
Stage2-vs-Stage3
9.423200E-01
Stage2-vs-Stage4
3.839800E-01
Stage3-vs-Stage4
5.927400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.344800E-01
Normal-vs-AfricanAmerican
2.597200E-01
Normal-vs-Asian
3.755400E-01
Caucasian-vs-AfricanAmerican
8.284000E-01
Caucasian-vs-Asian
8.635400E-01
AfricanAmerican-vs-Asian
7.313600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.065800E-01
Normal-vs-Female
4.260800E-01
Male-vs-Female
8.172800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.795400E-01
Normal-vs-Age(41-60Yrs)
2.489800E-01
Normal-vs-Age(61-80Yrs)
4.470400E-01
Normal-vs-Age(81-100Yrs)
6.612200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.773900E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.620770E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.293800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.282600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.042230E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.080040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.907000E-01
Normal-vs-Daily Drinker
5.972000E-01
Normal-vs-Weekly Drinker
4.305900E-02
Normal-vs-Occasional Drinker
5.425600E-01
Normal-vs-Social Drinker
3.032600E-01
Non Drinker-vs-Daily Drinker
8.038600E-01
Non Drinker-vs-Weekly Drinker
1.704560E-01
Non Drinker-vs-Occasional Drinker
7.352400E-01
Non Drinker-vs-Social Drinker
2.170000E-01
Daily Drinker-vs-Weekly Drinker
3.395600E-01
Daily Drinker-vs-Occasional Drinker
9.390600E-01
Daily Drinker-vs-Social Drinker
4.080800E-01
Weekly Drinker-vs-Occasional Drinker
3.762600E-01
Weekly Drinker-vs-Social Drinker
8.644400E-01
Occasional Drinker-vs-Social Drinker
4.484200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.678400E-01
Normal-vs-Grade 2
5.171700E-02
Normal-vs-Grade 3
6.598000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.60199999999345E-05
Grade 1-vs-Grade 3
9.55240000000135E-05
Grade 1-vs-Grade 4
4.678400E-01
Grade 2-vs-Grade 3
3.168400E-01
Grade 2-vs-Grade 4
5.171700E-02
Grade 3-vs-Grade 4
6.598000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.031200E-01
Normal-vs-NonDiabetic
4.179200E-01
Diabetic-vs-NonDiabetic
8.315200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.920200E-01
Normal-vs-NoPancreatitis
4.708400E-01
Pancreatitis-vs-NoPancreatitis
5.330200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.654400E-01
Normal-vs-N1
3.157200E-01
N0-vs-N1
4.485600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.514990E-01
Normal-vs-TP53-NonMutant
8.364600E-01
TP53-Mutant-vs-TP53-NonMutant
3.211400E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
